Cognitive impairment in acute ischemic stroke patients with early versus delayed antihypertensive treatment: A prespecified analysis of CATIS-2 trial
- 18 November 2025
- journal article
- Published by SAGE Publications in International Journal of Stroke
- Vol. 21 (7) , 999-1008
Abstract
Background: The optimal timing for initiating antihypertensive therapy after acute ischemic stroke (AIS), particularly regarding cognitive outcomes, remains uncertain. This study investigated the association between treatment timing and 3-month cognitive function. Methods: This prespecified analysis of the China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2) included patients completing 3-month Montreal Cognitive Assessment (MoCA). Participants were randomized to early (immediate) or delayed (day 8) antihypertensive treatment, with MoCA score as primary outcome. Results: A total of 1682 patients completed the cognitive assessment; 823 received early antihypertensive treatment and 859 received delayed treatment. Baseline characteristics were comparable between the two groups. The median MoCA score was 23 in both groups (β, -0.06; 95% CI, -0.16 to 0.03; P = .19). In addition, the proportion of individuals with MoCA scores < 25 was similar between the two groups (62% vs 59%; OR, 1.15; 95% CI, 0.95 to 1.40; P = 0.16). Exploratory subgroup analyses suggested a potential interaction by prior antihypertensive use, whereby early antihypertensive treatment was associated with worse cognitive outcomes in patients with prior antihypertensive use (OR, 1.34; 95% CI, 1.01–1.77; p = 0.03; P for interaction = 0.04). Conclusions: Early antihypertensive initiation did not improve 3-month cognitive outcomes in AIS patients, highlighting the importance of individualized therapy, especially for high-risk PSCI subgroups.Keywords
Funding Information
- the Ministry of Science and Technology of the People’s Republic of China (2016YFC1307300, 2016YFC1307301 and 2016YFC1307302)
- China Postdoctoral Science Foundation (2025M772293, GZC20251492)
- National Natural Science Foundation of China (grant number 82071301 and 81820108012)
This publication has 35 references indexed in Scilit:
- Early vs Delayed Antihypertensive Treatment in Acute Single Subcortical InfarctionJAMA Network Open, 2024
- Optimal cut-off MoCA score for screening for mild cognitive impairment in elderly individuals in China: A systematic review and meta-analysisAsian Journal of Psychiatry, 2023
- Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta‐analysisAlzheimer's & Dementia, 2023
- Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular StudyThe Lancet Neurology, 2019
- The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and DiseaseNeuron, 2017
- High Morning and Bedtime Home Blood Pressures Strongly Predict for Post-Stroke Cognitive ImpairmentJournal of Stroke and Cerebrovascular Diseases, 2016
- The Diagnosis and Management of Mild Cognitive ImpairmentJAMA, 2014
- Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trialThe Lancet Neurology, 2014
- Effects of Immediate Blood Pressure Reduction on Death and Major Disability in Patients With Acute Ischemic StrokeJAMA, 2014
- The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trialThe Lancet, 2011